Clinical Trial Update: A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) [Phase 1]

View source ↗

Summary

A Phase 1 study of LY3938577 in healthy participants and individuals with Type 1 Diabetes Mellitus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• LY3938577

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Type 1 Diabetes Mellitus | Phase 1 | Status: RECRUITING